Use of Complementary and Alternative Medicine in Axial Spondyloarthritis: A Qualitative Exploration of Self-Management.
Abbie JordanHannah FamilyKelly BlaxallFiona M BegenAlice HeaneyPublished in: Journal of clinical medicine (2019)
Axial spondyloarthritis (axSpA) is an inflammatory rheumatic condition that is often subject to diagnostic delays. Individuals with axSpA report using complementary and alternative therapies prior to and following diagnosis, though little is known concerning reasons underlying use of such therapies. This study provides detailed insights into the motivation and experiences of complementary and alternative medicine use within a population of individuals with axSpA. Open-ended surveys were completed by 30 individuals (20-69 years; 17 females) diagnosed with axSpA. Subsequent telephone interviews were conducted with eight individuals (39-70 years; five females) diagnosed with axSpA. Data were analyzed using reflexive inductive thematic analysis. Themes of "a learning curve", "barriers to complementary and alternative therapy use" and "complementary or mutually exclusive" illustrated how participants" increasing understanding of their condition empowered them to explore complementary and alternative therapies use as an adjunct to mainstream care. Individuals with axSpA recommended greater integration between mainstream and complementary and alternative therapies, valuing informed advice from mainstream healthcare professionals before selecting appropriate complementary and alternative therapies for potential use. Healthcare professionals should be proactive in discussing complementary and alternative therapy use with patients and supply them with details of organizations that can provide good-quality information.
Keyphrases
- healthcare
- end stage renal disease
- rheumatoid arthritis
- stem cells
- minimally invasive
- systemic lupus erythematosus
- newly diagnosed
- cross sectional
- chronic kidney disease
- quality improvement
- ejection fraction
- machine learning
- palliative care
- mesenchymal stem cells
- bone marrow
- risk assessment
- prognostic factors
- disease activity
- health information